Literature DB >> 2941358

Ciprofloxacin for treating urethral gonorrhoea in men.

M Shahmanesh, S R Shukla, I Phillips, A Westwood, R N Thin.   

Abstract

The effectiveness of a single oral dose of ciprofloxacin in eradicating urethral gonorrhoea was assessed in 18 men who received 250 mg and 26 men who were given 100 mg. All patients, including two infected with beta lactamase (penicillinase) producing strains of Neisseria gonorrhoeae (PPNG), were cured. The drug had no effect on infection with Chlamydia trachomatis or on the incidence of post gonococcal urethritis. Ciprofloxacin may be useful in patients hypersensitive to penicillins and cephalosporins, and the drug may also be useful in urethral gonorrhoea caused by PPNG strains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941358      PMCID: PMC1011905          DOI: 10.1136/sti.62.2.86

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  4 in total

1.  Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence.

Authors:  I Phillips; D Humphrey; A Middleton; C S Nicol
Journal:  Br J Vener Dis       Date:  1972-08

2.  Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller; A Iliffe
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

3.  Beta-lactamase-producing, penicillin-resistant gonococcus.

Authors:  I Phillips
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

4.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

  4 in total
  10 in total

1.  Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains.

Authors:  J M Covino; M Cummings; B Smith; S Benes; K Draft; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 2.  Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Quinolones in non-gonococcal urethritis.

Authors:  E Monteiro; G R Kinghorn; R C Spencer
Journal:  Genitourin Med       Date:  1986-12

4.  Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.

Authors:  E Stolz; J H Wagenvoort; A H van der Willigen
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

5.  Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.

Authors:  E W Hook; R B Jones; D H Martin; G A Bolan; T F Mroczkowski; T M Neumann; J J Haag; R Echols
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

6.  Ciprofloxacin treatment of chlamydial infections of urogenital tracts of women.

Authors:  I H Ahmed-Jushuf; O P Arya; D Hobson; B C Pratt; C A Hart; S J How; I A Tait; P M Rao
Journal:  Genitourin Med       Date:  1988-02

7.  Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].

Authors:  L L Cheong; R K Chan; M Nadarajah
Journal:  Genitourin Med       Date:  1992-08

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Enoxacin as one day oral treatment of men with anal or pharyngeal gonorrhoea.

Authors:  M Bakhtiar; P L Samarasinghe
Journal:  Genitourin Med       Date:  1988-12

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.